• Understand that adrenergic receptor (AR) antagonists reduce hemangiosaroma cell viability through receptor-independent mechanisms.
• Understand how AR antagonists alter metaabolic pathways to reduce hemangiosarcoma cell viablity.
• Understand that AR antagonists synergize with chemotherapies to kill tumor cells.